Tyrosine kinase inhibitors in patients with radioiodine-refractory, differentiated thyroid cancer Is there an optimal timepoint for their use?
Rendl, G; Schweighofer-Zwink, G; Pirich, C
AUST J CLIN ENDOCR M. 2023;
Originalarbeiten (Zeitschrift)

Evolving Role of [
Seyedinia, SS; Mirshahvalad, SA; Schweighofer-Zwink, G; Hehenwarter, L; Rendl, G; Pirich, C; Beheshti, M;
J Clin Med. 2023; 12(3):
Originalarbeiten (Zeitschrift)

18F Choline PET/CT in a patient with HRPT2 mutation: Detecting parathyroid carcinoma recurrence and concomitant breast carcinoma.
Radzikowski, KC; Rendl, G; Beheshti, M; Pirich, C;
Nuklearmedizin. 2022; 61(1):62-64
Fallberichte

Assessment of Treatment Response to Lenvatinib in Thyroid Cancer Monitored by F-18 FDG PET/CT Using PERCIST 1.0, Modified PERCIST and EORTC Criteria-Which One Is Most Suitable?
Rendl, G; Schweighofer-Zwink, G; Sorko, S; Gallowitsch, HJ; Hitzl, W; Reisinger, D; Pirich, C
CANCERS. 2022; 14(8):
Originalarbeiten (Zeitschrift)

Impact of F-18-Fluorocholine PET/CT in the Assessment of Patients with Normocalcemic or Normohormonal Primary Hyperparathyroidism
Mirshahvalad, S; Seyedinia, S; Rendl, G; Hehenwarter, L; Pirich, C; Beheshti, M
EUR J NUCL MED MOL I. 2022; 49(SUPPL 1): S134-S135.
Abstracts (Zeitschrift)

Additional late imaging in diuretic renography
Pilz, J; Steinkellner, L; Rendl, G; Schweighofer-Zwink, G; Pirich, C; Dierneder, J
EUR J NUCL MED MOL I. 2022; 49(SUPPL 1): S573-S574.
Abstracts (Zeitschrift)

Feasibility of equivalent performance of 3D TOF [
Pilz, J; Hehenwarter, L; Zimmermann, G; Rendl, G; Schweighofer-Zwink, G; Beheshti, M; Pirich, C;
EJNMMI RES. 2021; 11(1): 44
Originalarbeiten (Zeitschrift)

Feasibility of 3D TOF PET/CT scanning with reduced [F-18]-FDG activity obtaining equivalent clinical and semi-quantitative parameters
Pilz, J; Hehenwarter, L; Schweighofer-Zwink, G; Rendl, G; Beheshti, M; Pirich, C
EUR J NUCL MED MOL I. 2021; 48(SUPPL 1): S274-S275.
Abstracts (Zeitschrift)

Pre-Ablation rhTSH-Stimulated F-18 FDG PET/CT Changes Patient Management in Increased-Risk Thyroid Cancer.
Rendl, G; Rettenbacher, L; Schweighofer-Zwink, G; Hehenwarter, L; Pirich, C
HORM METAB RES. 2020; 52(3): 158-167.
Originalarbeiten (Zeitschrift)

Real-World Data for Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer (RELEVANT): A Retrospective Multicentric Analysis of Clinical Practice in Austria.
Rendl, G; Sipos, B; Becherer, A; Sorko, S; Trummer, C; Raderer, M; Hitzl, W; Ardelt, M; Gallowitsch, HJ; Pirich, C;
Int J Endocrinol. 2020; 2020: 8834148
Originalarbeiten (Zeitschrift)

Para-aortal Ganglion Mimicking a Lymph Node Metastases on 68Ga-PSMA PET/CT.
Zwink, GS; Rendl, G; Schmeller, N; Pirich, C
CLIN NUCL MED. 2020; 45(11): 883-885.
Fallberichte

Reduction of [F-18]-FDG activity applied is feasible in clinical routine for 3D TOF PET/CT scanner: A retrospective patient study
Pilz, J; Hehenwarter, L; Rendl, G; Schweighofer-Zwink, G; Pirich, C
EUR J NUCL MED MOL I. 2020; 47(SUPPL 1): S155-S155.
Abstracts (Zeitschrift)

F-18 Choline PET-CT is valuable in the assessment of normocalcemic primary hyperparathyroidism
Pirich, C; Schaffler-Schaden, D; Schweighofer-Zwink, G; Rendl, G; Hehenwarter, L; Beheshti, M
EUR J NUCL MED MOL I. 2020; 47(SUPPL 1): S133-S133.
Abstracts (Zeitschrift)

Value of interim F-18 FDG PET/CT imaging in patients with metastatic radioiodine-refractory thyroid carcinoma undergoing tyrosine-kinase inhibition therapy
Rendl, G; Sipos, B; Hehenwarter, L; Schweighofer-Zwink, G; Gallowitsch, H; Pirich, C
EUR J NUCL MED MOL I. 2020; 47(SUPPL 1): S32-S33.
Abstracts (Zeitschrift)

[Imaging of parathyroid adenomas with F‑18 choline PET-CT].
Schweighofer-Zwink, G; Hehenwarter, L; Rendl, G; Rettenbacher, L; Langsteger, W; Beheshti, M; Pirich, C;
Wien Med Wochenschr. 2019; 169(1-2):15-24
Originalarbeiten (Zeitschrift)

F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with
Beheshti, M; Hehenwarter, L; Paymani, Z; Rendl, G; Imamovic, L; Rettenbacher, R; Tsybrovskyy, O; Langsteger, W; Pirich, C;
Eur J Nucl Med Mol Imaging. 2018; 45(10):1762-1771
Originalarbeiten (Zeitschrift)

Dual point imaging using 18F-fluorocholine PET/CT for detection of parathyroid adenoma
Hehenwarter, L; Schweighofer-Zwink, G; Rendl, G; Beheshti, M; Rettenbacher, L; Pirich, C
EUR J NUCL MED MOL I. 2018; 45: S90-S90.
Abstracts (Zeitschrift)

Pre-ablation rhTSH-stimulated F-18 FDG PET/CT changes patient management in intermediate to high-risk thyroid cancer even in the presence of low thyroglobulin levels
Rendl, G; Rettenbacher, L; Schweighofer-Zwink, G; Hehenwarter, L; Pirich, C
EUR J NUCL MED MOL I. 2018; 45: S552-S552.
Abstracts (Zeitschrift)

Imaging and reconstruction Parameters using PET/CT for post therapeutic Imaging after Y90 SIRT - a feasibility study
Zwink, GS; Hehenwarter, L; Rettenbacher, L; Holzmannhofer, J; Rendl, G; Pirich, C
EUR J NUCL MED MOL I. 2018; 45: S723-S724.
Abstracts (Zeitschrift)

Diagnostic accuracy and functional parameters of myocardial perfusion scintigraphy using accelerated cardiac acquisition with IQ SPECT technique in comparison to conventional imaging.
Pirich, C; Keinrath, P; Barth, G; Rendl, G; Rettenbacher, L; Rodrigues, M;
Q J Nucl Med Mol Imaging. 2017; 61(1): 102-107.
Originalarbeiten (Zeitschrift)

Clinicopathological characteristics of thyroid cancer in the federal state of Salzburg
Rendl, G; Rodrigues, M; Schweighofer-Zwink, G; Hutter, J; Hittmair, A; Zellinger, B; Hauser-Kronberger, C; Pirich, C
WIEN KLIN WOCHENSCHR. 2017; 129(15-16): 540-544.
Originalarbeiten (Zeitschrift)

32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016.
Langsteger, W; Rezaee, A; Loidl, W; Geinitz, HS; Fitz, F; Steinmair, M; Broinger, G; Pallwien-Prettner, L; Beheshti, M; Imamovic, L; Beheshti, M; Rendl, G; Hackl, D; Tsybrovsky, O; Steinmair, M; Emmanuel, K; Moinfar, F; Pirich, C; Langsteger, W; Bytyqi, A; Karanikas, G; Mayerhöfer, M; Koperek, O; Niederle, B; Hartenbach, M; Beyer, T; Herrmann, K; Czernin, J; Rausch, I; Rust, P; DiFranco, MD; Lassen, M; Stadlbauer, A; Mayerhöfer, ME; Hartenbach, M; Hacker, M; Beyer, T; Binzel, K; Magnussen, R; Wei, W; Knopp, MU; Flanigan, DC; Kaeding, C; Knopp, MV; Leisser, A; Nejabat, M; Hartenbach, M; Kramer, G; Krainer, M; Hacker, M; Haug, A; Lehnert, W; Schmidt, K; Kimiaei, S; Bronzel, M; Kluge, A; Wright, CL; Binzel, K; Zhang, J; Wuthrick, E; Maniawski, P; Knopp, MV; Blaickner, M; Rados, E; Huber, A; Dulovits, M; Kulkarni, H; Wiessalla, S; Schuchardt, C; Baum, RP; Knäusl, B; Georg, D; Bauer, M; Wulkersdorfer, B; Wadsak, W; Philippe, C; Haslacher, H; Zeitlinger, M; Langer, O; Bauer, M; Feldmann, M; Karch, R; Wadsak, W; Zeitlinger, M; Koepp, MJ; Asselin, MC; Pataraia, E; Langer, O; Zeilinger, M; Philippe, C; Dumanic, M; Pichler, F; Pilz, J; Hacker, M; Wadsak, W; Mitterhauser, M; Nics, L; Steiner, B; Hacker, M; Mitterhauser, M; Wadsak, W; Traxl, A; Wanek, T; Kryeziu, K; Mairinger, S; Stanek, J; Berger, W; Kuntner, C; Langer, O; Mairinger, S; Wanek, T; Traxl, A; Krohn, M; Stanek, J; Filip, T; Sauberer, M; Kuntner, C; Pahnke, J; Langer, O; Svatunek, D; Denk, C; Wilkovitsch, M; Wanek, T; Filip, T; Kuntner-Hannes, C; Fröhlich, J; Mikula, H; Denk, C; Svatunek, D; Wanek, T; Mairinger, S; Stanek, J; Filip, T; Fröhlich, J; Mikula, H; Kuntner-Hannes, C; Balber, T; Singer, J; Fazekas, J; Rami-Mark, C; Berroterán-Infante, N; Jensen-Jarolim, E; Wadsak, W; Hacker, M; Viernstein, H; Mitterhauser, M; Denk, C; Svatunek, D; Sohr, B; Mikula, H; Fröhlich, J; Wanek, T; Kuntner-Hannes, C; Filip, T; Pfaff, S; Philippe, C; Mitterhauser, M; Hartenbach, M; Hacker, M; Wadsak, W; Wanek, T; Halilbasic, E; Visentin, M; Mairinger, S; Stieger, B; Kuntner, C; Trauner, M; Langer, O; Lam, P; Aistleitner, M; Eichinger, R; Artner, C; Eidherr, H; Vraka, C; Haug, A; Mitterhauser, M; Nics, L; Hartenbach, M; Hacker, M; Wadsak, W; Kvaternik, H; Müller, R; Hausberger, D; Zink, C; Aigner, RM; Cossío, U; Asensio, M; Montes, A; Akhtar, S; Te Welscher, Y; van Nostrum, R; Gómez-Vallejo, V; Llop, J; VandeVyver, F; Barclay, T; Lippens, N; Troch, M; Hehenwarter, L; Egger, B; Holzmannhofer, J; Rodrigues-Radischat, M; Pirich, C; Pötsch, N; Rausch, I; Wilhelm, D; Weber, M; Furtner, J; Karanikas, G; Wöhrer, A; Mitterhauser, M; Hacker, M; Traub-Weidinger, T; Cassou-Mounat, T; Balogova, S; Nataf, V; Calzada, M; Huchet, V; Kerrou, K; Devaux, JY; Mohty, M; Garderet, L; Talbot, JN; Stanzel, S; Pregartner, G; Schwarz, T; Bjelic-Radisic, V; Liegl-Atzwanger, B; Aigner, R; Stanzel, S; Quehenberger, F; Aigner, RM; Marković, AK; Janković, M; Jerković, VM; Paskaš, M; Pupić, G; Džodić, R; Popović, D; Fornito, MC; Familiari, D; Koranda, P; Polzerová, H; Metelková, I; Henzlová, L; Formánek, R; Buriánková, E; Kamínek, M; Thomson, WH; Lewis, C; Thomson, WH; OBrien, J; James, G; Notghi, A; Huber, H; Stelzmüller, I; Wunn, R; Mandl, M; Fellner, F; Lamprecht, B; Gabriel, M; Fornito, MC; Leonardi, G; Thomson, WH; OBrien, J; James, G; Hudzietzová, J; Sabol, J; Fülöp, M;
EJNMMI Res. 2016; 6(Suppl 1):32
Abstracts (Zeitschrift)

Diagnostic performance of [18F] FDG PET-CT compared to bone scintigraphy for the detection of bone metastases in lung cancer patients.
Rodrigues, M; Stark, H; Rendl, G; Rettenbacher, L; Datz, L; Studnicka, M; Pirich, C;
Q J Nucl Med Mol Imaging. 2016; 60(1): 62-68.
Originalarbeiten (Zeitschrift)

Expression of Tenascin C, EGFR, E-Cadherin, and TTF-1 in Medullary Thyroid Carcinoma and the Correlation with RET Mutation Status
Steiner, F; Hauser-Kronberger, C; Rendl, G; Rodrigues, M; Pirich, C
INT J MOL SCI. 2016; 17(7): 1093-1101.
Originalarbeiten (Zeitschrift)

Pre-ablation rhTSH-stimulated F-18 FDG PET/CT changes patient management in increased-risk thyroid cancer
Rendl, G; Rettenbacher, L; Schweighofer-Zwink, G; Hofstetter-Horl, K; Pirich, C
EUR J NUCL MED MOL I. 2016; 43: S367-S367.
Abstracts (Zeitschrift)

Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer.
Rendl, G; Rettenbacher, L; Holzmannhofer, J; Datz, L; Hauser-Kronberger, C; Fastner, G; Ofner, D; Sedlmayer, F; Pirich, C;
Ann Nucl Med. 2015; 29(3): 284-294.
Originalarbeiten (Zeitschrift)

Long-term survival of patients with manifested coronary artery disease with and without diabetes undergoing myocardial viability assessment.
Rendl, G; Keinrath, P; Krommes, K; Barth, G; Holzmannhofer, J; Pirich, C
EUR J NUCL MED MOL I. 2015; 42: S532-S532.
Abstracts (Zeitschrift)

99mTc tetrofosmin myocardial perfusion scintigraphy in CAD. Performance with early and standard delayed acquisition and fractional flow reserve.
Pirich, C; Keinrath, P; Rettenbacher, L; Rendl, G; Holzmannhofer, J; Hammerer, M; Schuler, J; Beheshti, M;
Nuklearmedizin. 2014; 53(3):111-116
Originalarbeiten (Zeitschrift)

Incidental breast cancer in a male patient on cardiac PET-CT.
Rendl, G; Rettenbacher, L; Rodrigues, M; Pirich, C
Breast J. 2014; 20(6):660-662
Kurzberichte/Notes

The impact of PET and PET/CT on treatment planning and prognosis of patients with NSCLC treated with radiation therapy.
Nawara, C; Rendl, G; Wurstbauer, K; Lackner, B; Rettenbacher, L; Datz, L; Studnicka, M; Sedlmayer, F; Pirich, C;
Q J Nucl Med Mol Imaging. 2012; 56(2): 19-201.
Originalarbeiten (Zeitschrift)

Failure of pentagastrin-stimulated calcitonin testing in early manifestation of familial medullary thyroid cancer.
Pirich, C; Rendl, G; Hauser-Kronberger, C; Häusler, I;
Wien Klin Wochenschr. 2012; 124(19-20): 723-724.
Fallberichte

Diagnostic Accuracy and Functional Parameters in Tc-99m tetrofosmine Myocardial Perfusion Scintigraphy using Accelerated Cardiac Aquisition with IQ SPECT Technique in Comparison to Conventional Imaging
Pirich, C; Keinrath, P; Barth, G; Rendl, G; Krammel, F; Rettenbacher, L
EUR J NUCL MED MOL I. 2012; 39: S285-S286.
Abstracts (Zeitschrift)

Lymphoscintigraphy in breast cancer patients after neoadjuvant chemotherapy Diagnostic value and the work-up of sentinel node negative patients
Dalus, K; Reitsamer, R; Holzmannhofer, J; Rendl, G; Pirich, C; Kronberger, C; Rettenbacher, L
NUKLEARMED-NUCL MED. 2011; 50(1): 33-38.
Originalarbeiten (Zeitschrift)

FDG PET/CT for monitoring response to neoadjuvant chemotherapy in breast cancer patients.
Dalus, K; Rendl, G; Rettenbacher, L; Pirich, C;
EUR J NUCL MED MOL I. 2010; 37(10): 1992-1993.
Letter

Different pattern of regional metabolic abnormalities in Takotsubo cardiomyopathy as evidenced by F-18 FDG PET-CT
Rendl, G; Rettenbacher, L; Keinrath, P; Altenberger, J; Schuler, J; Heigert, M; Pichler, M; Pirich, C
WIEN KLIN WOCHENSCHR. 2010; 122(5-6): 184-185.
Letter

High Tenascin-C expression marks active breast cancer tissue in neoadjuvantly treated patients
Bastelberger, S; Hinterseer, E; Pradel, L; Beil, J; Rendl, G; Dietze, O; Kronberger, HC
FEBS J. 2010; 277: 200-201.
Abstracts (Zeitschrift)

Regional pattern and course of metabolic abnormalities in Takotsubo cardiomyopathy as evidenced by F-18 FDG PET-CT
Rendl, G; Rettenbacher, L; Altenberger, J; Schuler, J; Heigert, M; Pichler, M; Pirich, C
EUR HEART J SUPPL. 2009; 11(B): S79-S79.
Abstracts (Zeitschrift)

Comparison of the PET-tracer F-18 FLT and F-18 FDG in patients with rectal cancer: diagnostic value before and after neoadjuvant radiochemotherapy
Rendl, G; Rettenbacher, L; Holzmannhofer, J; Seifen, T; Datz, L; Schneider, A; Fastner, G; Sedlmayer, F; Pirich, C
EUR J NUCL MED MOL I. 2009; 36: S262-S262.
Abstracts (Zeitschrift)

Long-term prognosis of medullary thyroid carcinoma.
Rendl, G; Manzl, M; Hitzl, W; Sungler, P; Pirich, C;
CLIN ENDOCRINOL. 2008; 69(3): 497-505.
Originalarbeiten (Zeitschrift)

[18F]FETO: metabolic considerations.
Ettlinger, DE; Wadsak, W; Mien, LK; Machek, M; Wabnegger, L; Rendl, G; Karanikas, G; Viernstein, H; Kletter, K; Dudczak, R; Mitterhauser, M;
Eur J Nucl Med Mol Imaging. 2006; 33(8): 928-931.
Originalarbeiten (Zeitschrift)

Cardiac Imaging in Acute Coronary Syndromes and Acute Myocardial Infarction – An Update
Rendl, G; Altenberger, J; Pirich, C;
Imaging decisions (Berlin, Germany). 2006; 10 (3): 21-31.
Originalarbeiten (Zeitschrift)

Takotsubo cardiomyopathy in positron emission tomography.
Rendl, G; Altenberger, J; Pirich, C;
WIEN KLIN WOCHENSCHR. 2006; 118(17-18): 520
Kurzberichte/Notes

[18F]FETO for adrenocortical PET imaging: a pilot study in healthy volunteers.
Wadsak, W; Mitterhauser, M; Rendl, G; Schuetz, M; Mien, LK; Ettlinger, DE; Dudczak, R; Kletter, K; Karanikas, G;
Eur J Nucl Med Mol Imaging. 2006; 33(6): 669-672.
Originalarbeiten (Zeitschrift)